- Home
- CURV vs COEP Comparison
CURV vs COEP Comparison
Compare CURV & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURV | COEP |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.0M | 100.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CURV | COEP |
|---|---|---|
| Price | $1.10 | $11.49 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $1.59 | N/A |
| AVG Volume (30 Days) | ★ 251.3K | 47.2K |
| Earning Date | 03-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.36 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,103,737,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $110.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $6.32 |
| 52 Week High | $6.95 | $21.41 |
Technical Indicators
Market Signals| Indicator | CURV | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 37.46 |
| Support Level | $1.00 | $11.00 |
| Resistance Level | $1.07 | $12.40 |
| Average True Range (ATR) | 0.07 | 1.12 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 23.75 | 14.13 |
Price Performance
Historical ComparisonAbout CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.